Vitamin D and Ischaemic Heart Disease: A Casual or A Causal Association?

Rizzoni, Damiano; Rizzoni, Marco; Nardin, Matteo

doi:10.1007/s40292-019-00302-y

Cited by 2 publications

(1 citation statement)

References 43 publications

(54 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, low serum levels of vitamin D have been strongly associated with increased risk of numerous cardiovascular illnesses. Patients who experienced stable coronary artery disease and acute myocardial infarction were demonstrated to have decreased levels of vitamin D (57). Likewise, a meta-analysis which evaluated the relationship between this molecule and the risk of atrial fibrillation concluded that vitamin D deficiency significantly increases the risk of atrial fibrillation (58).…”

Section: Appraising the Risk Of Heart Disease In Patients With Pdmentioning

confidence: 99%

Parkinson's disease and cardiovascular involvement: Edifying insights (Review)

Grosu

Crişan

et al. 2023

Biomed Rep

View full text Add to dashboard Cite

Parkinson's disease (PD) is one of the most common neurodegenerative illnesses, and is a major healthcare burden with prodigious consequences on life-quality, morbidity, and survival. Cardiovascular diseases are the leading cause of mortality worldwide and growing evidence frequently reports their co-existence with PD. Cardiac dysautonomia due to autonomic nervous system malfunction is the most prevalent type of cardiovascular manifestation in these patients, comprising orthostatic and postprandial hypotension, along with supine and postural hypertension. Moreover, many studies have endorsed the risk of patients with PD to develop ischemic heart disease, heart failure and even arrhythmias, but the underlying mechanisms are not entirely clear. As importantly, the medication used in treating PD, such as levodopa, dopamine agonists or anticholinergic agents, is also responsible for cardiovascular adverse reactions, but further studies are required to elucidate the underlying mechanisms. The purpose of this review was to provide a comprehensive overview of current available data regarding the overlapping cardiovascular disease in patients with PD. Contents1. Background 2. Cardiovascular dysautonomia in patients with PD 3. Appraising the risk of heart disease in patients with PD 4. PD therapy related to cardiovascular disease 5. Conclusion

show abstract

Section: Appraising the Risk Of Heart Disease In Patients With Pdmentioning

confidence: 99%